Nascent Pharma Holdings, Inc. (OTCPK: NASC)
Health Care · Pharmaceuticals · US
$0.01
-9.97% today · -58.0% 1Y
Nascent Pharma Holdings, Inc. (OTCPK: NASC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.22M and employs 12 people.
Over the last twelve months the share price has lost 58.0%, trading between 0.01 and 0.04.
Tweenvest scores Nascent Pharma Holdings, Inc. across four factors: quality 13/100, value 43/100, growth 100/100. Its strongest factor is growth.
NASC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.22M
- Revenue (TTM)
- $1.03M
- P/E
- —
- EPS
- -0.29
- Dividend yield
- —
- Beta (5Y)
- 0.68
- 52-week high
- $0.04
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 144.89M
- Employees
- 12
- Next earnings
- —
About Nascent Pharma Holdings, Inc.
Nascent Pharma Holdings, Inc. is primarily engaged in both protecting and bringing to market intellectual property pertaining to cannabis. Beyond this, the company also manufactures superfood beverage mixes, which are marketed under its "Longevity" brand. Established in 2005 and headquartered in Hicksville, New York, the firm previously operated as Can B Corp. and is slated to officially adopt the Nascent Pharma Holdings, Inc. name in September 2025.
- ISIN
- US63108T1051
- Founded
- 2005
- Listed since
- Aug 3, 2012
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.